Literature DB >> 15261873

The refractory period of fast conducting corticospinal tract axons in man and its implications for intraoperative monitoring of motor evoked potentials.

Klaus Novak1, Adauri Bueno de Camargo, Michael Neuwirth, Karl Kothbauer, Vahe E Amassian, Vedran Deletis.   

Abstract

OBJECTIVE: To determine the absolute and relative refractory period (RRP) of fast conducting axons of the corticospinal tract in response to paired high intensity (HI or supramaximal) and moderate intensity (MI or submaximal) electrical stimuli. The importance of the refractory period of fast conducting corticospinal tract axons has to be considered if repetitive transcranial electrical stimulation (TES) is to be effective for eliciting motor evoked potentials (MEPs) intraoperatively.
METHODS: Direct (D) waves were recorded from the epidural space of the spinal cord in 14 patients, undergoing surgical correction of spinal deformities. To assess the absolute and RRPs of the corticospinal tract, paired transcranial electrical stimuli at interstimulus intervals (ISI) from 0.7 to 4.1 ms were applied. Recovery of conditioned D wave at short (2 ms) and long (4 ms) ISI was correlated with muscle MEP threshold. The refractory period for peripheral nerve was tested in comparison to that for the corticospinal tract. In four healthy subjects sensory nerve action potentials of the median nerve were studied after stimulation with paired stimuli.
RESULTS: HI TES revealed a mean duration of 0.82 ms for the absolute refractory period of the corticospinal tract, while MI stimulation resulted in a mean refractory period duration of 1.47 ms. Stimuli of HI produced faster recovery of D wave amplitude during the RRP. Furthermore, short trains of transcranial electrical stimuli did not elicit MEPs when D wave showed incomplete recovery. A similar influence of stimulus intensity on recovery time was found for the refractory period of peripheral nerve.
CONCLUSIONS: The recovery of D wave amplitude is dependent upon stimulus intensity. High intensity produces fast recovery. This is an important factor for the generation of MEPs. When HI TES is used to elicit MEPs, short and long ISIs are equally effective. When MI TES is used to elicit MEPs, only a long ISI of 4 ms is effective.

Entities:  

Mesh:

Year:  2004        PMID: 15261873     DOI: 10.1016/j.clinph.2004.03.016

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Predicted current densities in the brain during transcranial electrical stimulation.

Authors:  R N Holdefer; R Sadleir; M J Russell
Journal:  Clin Neurophysiol       Date:  2006-04-27       Impact factor: 3.708

Review 2.  Intraoperative motor evoked potential monitoring: overview and update.

Authors:  David B Macdonald
Journal:  J Clin Monit Comput       Date:  2006-07-11       Impact factor: 2.502

3.  Feasibility and efficacy of transcranial motor-evoked potential monitoring in neuroendovascular surgery.

Authors:  T G Horton; M Barnes; S Johnson; P C Kalapos; A Link; K M Cockroft
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-19       Impact factor: 3.825

4.  Latency of subthalamic nucleus deep brain stimulation-evoked cortical activity as a potential biomarker for postoperative motor side effects.

Authors:  Zachary T Irwin; Mohammad Z Awad; Christopher L Gonzalez; Arie Nakhmani; J Nicole Bentley; Thomas A Moore; Kenneth G Smithson; Barton L Guthrie; Harrison C Walker
Journal:  Clin Neurophysiol       Date:  2020-03-12       Impact factor: 3.708

5.  Intracortical circuits modulate transcallosal inhibition in humans.

Authors:  L Avanzino; J T H Teo; J C Rothwell
Journal:  J Physiol       Date:  2007-06-07       Impact factor: 5.182

6.  Paired-Pulse TMS and Fine-Wire Recordings Reveal Short-Interval Intracortical Inhibition and Facilitation of Deep Multifidus Muscle Fascicles.

Authors:  Hugo Massé-Alarie; Edith Elgueta Cancino; Cyril Schneider; Paul Hodges
Journal:  PLoS One       Date:  2016-08-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.